Pakistan Business News API

                            {
    "totalArticles": 3178580,
    "articles": [
        {
            "id": "a20dc0247e43dcc81d48f5e0aee3d209",
            "title": "Microsoft profits soar almost 25% on boom in cloud computing revenues",
            "description": "Shares in US tech giant rise in after-hours trading",
            "content": "Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.\nMicrosoft said its quarterly profits soared as revenues from its cloud computing division surged to a record level, driven by rampant demand for artificial intel... [1627 chars]",
            "url": "https://www.ft.com/content/922d3d3c-c614-4273-b2d3-6ddb95714536",
            "image": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2Ff173bb27-2aae-4705-8c61-48d552262fe9.jpg?source=next-article&fit=scale-down&quality=highest&width=700&dpr=1",
            "publishedAt": "2025-07-30T20:21:02Z",
            "source": {
                "id": "d922e72550911d33239ec0ae33b2a143",
                "name": "Financial Times",
                "url": "https://www.ft.com"
            }
        },
        {
            "id": "c86d8413ccf66e252c12492e99423cbe",
            "title": "IIF/ISDA Response to BoE Consultation on Banks’ and Insurers’ Management of Climate-related Risks",
            "description": "On July 30, the IIF and ISDA submitted comments on the Bank of England's Consultation Paper 10/25, “Enhancing banks’ and insurers’ approaches to manag...",
            "content": "On July 30, the Institute of International Finance (IIF) and International Swaps and Derivatives Association (ISDA), on behalf of their respective global financial services industry members, submitted comments on the Bank of England's Consultation Pa... [1657 chars]",
            "url": "https://www.iif.com/Publications/ID/6245/IIFISDA-Response-to-BoE-Consultation-on-Banks-and-Insurers-Management-of-Climate-related-Risks",
            "image": "https://www.iif.com/Portals/0/IIF_logo_card_blue.png",
            "publishedAt": "2025-07-30T20:19:28Z",
            "source": {
                "id": "97d1259dc13ff0bbb22dc473d509a0a7",
                "name": "Institute of International Finance | IIF",
                "url": "https://www.iif.com"
            }
        },
        {
            "id": "6ec92c5d5fd7734a10e7a65c6f0c96ce",
            "title": "Biomarkers May Inform Potential Role for Ipilimumab/Nivolumab in Untreated Metastatic Urothelial Cancer After Missing OS End Point",
            "description": "Guru P. Sonpavde, MD, discusses the role of ipilimumab/nivolumab after negative trial results in managing advanced urothelial cancer.",
            "content": "Guru P. Sonpavde, MD\nThe combination of ipilimumab (Yervoy) and nivolumab (Opdivo) did not meet the dual primary end points of overall survival (OS) in patients with previously untreated unresectable or metastatic urothelial cancer in the cisplatin-i... [6712 chars]",
            "url": "https://www.onclive.com/view/biomarkers-may-inform-potential-role-for-ipilimumab-nivolumab-in-untreated-metastatic-urothelial-cancer-after-missing-os-end-point",
            "image": "https://cdn.sanity.io/images/0vv8moc6/onclive/65002fcca3480a42f2c6ecbdc9e387b059a51ab0-1200x1200.jpg?fit=crop&auto=format",
            "publishedAt": "2025-07-30T20:04:22Z",
            "source": {
                "id": "0da2d0b1fc86b8b05e122c750c98bd32",
                "name": "OncLive",
                "url": "https://www.onclive.com"
            }
        }
    ]
}